CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 118 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,173 | -76.7% | 3,351 | -73.2% | 0.00% | -83.3% |
Q2 2023 | $168,268 | +50736.3% | 12,520 | -37.2% | 0.01% | -45.5% |
Q1 2023 | $331 | +298.8% | 19,944 | +343.0% | 0.01% | +266.7% |
Q4 2022 | $83 | -100.0% | 4,502 | -82.1% | 0.00% | -40.0% |
Q3 2022 | $322,000 | +312.8% | 25,107 | +125.5% | 0.01% | +150.0% |
Q2 2022 | $78,000 | -78.0% | 11,132 | -73.9% | 0.00% | -33.3% |
Q1 2022 | $354,000 | +321.4% | 42,629 | +242.0% | 0.00% | +200.0% |
Q4 2021 | $84,000 | -24.3% | 12,465 | -40.7% | 0.00% | -66.7% |
Q3 2021 | $111,000 | +146.7% | 21,024 | +168.3% | 0.00% | +200.0% |
Q2 2021 | $45,000 | -32.8% | 7,837 | -45.7% | 0.00% | 0.0% |
Q1 2021 | $67,000 | +123.3% | 14,446 | +60.9% | 0.00% | 0.0% |
Q4 2020 | $30,000 | -93.9% | 8,979 | -94.5% | 0.00% | -80.0% |
Q3 2020 | $489,000 | +404.1% | 164,561 | +690.5% | 0.01% | +25.0% |
Q2 2020 | $97,000 | +73.2% | 20,818 | +38.8% | 0.00% | -20.0% |
Q4 2019 | $56,000 | +107.4% | 15,000 | +196.4% | 0.01% | +150.0% |
Q3 2019 | $27,000 | +28.6% | 5,061 | -53.0% | 0.00% | 0.0% |
Q4 2018 | $21,000 | +950.0% | 10,769 | +2320.0% | 0.00% | – |
Q3 2018 | $2,000 | -75.0% | 445 | -86.1% | 0.00% | -100.0% |
Q1 2018 | $8,000 | -83.7% | 3,198 | -74.8% | 0.00% | -83.3% |
Q4 2017 | $49,000 | +28.9% | 12,677 | -16.9% | 0.01% | +100.0% |
Q3 2017 | $38,000 | +1800.0% | 15,261 | +1424.6% | 0.00% | – |
Q1 2017 | $2,000 | -77.8% | 1,001 | -87.6% | 0.00% | -100.0% |
Q4 2016 | $9,000 | +12.5% | 8,097 | +5.0% | 0.00% | 0.0% |
Q3 2016 | $8,000 | -80.0% | 7,710 | -86.2% | 0.00% | -75.0% |
Q2 2016 | $40,000 | +700.0% | 55,783 | +1142.7% | 0.00% | +300.0% |
Q1 2016 | $5,000 | +25.0% | 4,489 | +158.0% | 0.00% | 0.0% |
Q4 2015 | $4,000 | -83.3% | 1,740 | -78.0% | 0.00% | -50.0% |
Q3 2015 | $24,000 | – | 7,901 | +7801.0% | 0.00% | – |
Q2 2015 | $0 | -100.0% | 100 | -97.7% | 0.00% | -100.0% |
Q1 2015 | $19,000 | +1800.0% | 4,301 | +705.4% | 0.00% | – |
Q1 2014 | $1,000 | -96.9% | 534 | -96.8% | 0.00% | -100.0% |
Q4 2013 | $32,000 | – | 16,540 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |